These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8073036)

  • 21. Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.
    Ambrosetti DC; Palla E; Mirtella A; Galeotti C; Solito E; Navarra P; Parente L; Melli M
    Eur J Biochem; 1996 Jun; 238(2):308-16. PubMed ID: 8681939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance.
    D'Ettorre C; De Chiara G; Casadei R; Boraschi D; Tagliabue A
    Eur Cytokine Netw; 1997 Jun; 8(2):161-71. PubMed ID: 9262965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor and antibody interactions of human interleukin-3 characterized by mutational analysis.
    Dorssers LC; Mostert MC; Burger H; Janssen C; Lemson PJ; van Lambalgen R; Wagemaker G; van Leen RW
    J Biol Chem; 1991 Nov; 266(31):21310-7. PubMed ID: 1718976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of type I IL-1 beta receptor fragment 151-162 to interleukin-1 beta.
    Fasina G; Verdoliva A; Cassani G; Melli M
    Growth Factors; 1994; 10(2):99-106. PubMed ID: 8068354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modularity of protein function: chimeric interleukin 1 beta s containing specific protease inhibitor loops retain function of both molecules.
    Wolfson AJ; Kanaoka M; Lau F; Ringe D; Young P; Lee J; Blumenthal J
    Biochemistry; 1993 May; 32(20):5327-31. PubMed ID: 8499437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1 beta protein.
    Auron PE; Quigley GJ; Rosenwasser LJ; Gehrke L
    Biochemistry; 1992 Jul; 31(29):6632-8. PubMed ID: 1386253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding.
    Weigel U; Meyer M; Sebald W
    Eur J Biochem; 1989 Mar; 180(2):295-300. PubMed ID: 2647490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of regions in interleukin-1 alpha important for activity.
    Gayle RB; Poindexter K; Cosman D; Dower SK; Gillis S; Hopp T; Jerzy R; Kronheim S; Lum V; Lewis A
    J Biol Chem; 1993 Oct; 268(29):22105-11. PubMed ID: 8408069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human N-terminal analogs of interleukin 1 beta demonstrate altered binding and function in hematopoiesis.
    Zucali JR; Moreb J; Newton RC; Huaog JJ
    Exp Hematol; 1990 Nov; 18(10):1078-82. PubMed ID: 2145179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular determinants of agonist and antagonist signaling through the IL-36 receptor.
    Günther S; Sundberg EJ
    J Immunol; 2014 Jul; 193(2):921-30. PubMed ID: 24935927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
    Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
    Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors.
    Tömösközi Z; Bugovics G; Koncz S; Arányi P
    Agents Actions; 1994 Mar; 41(1-2):105-7. PubMed ID: 8079812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysis.
    Lu J; Witcher DR; White MA; Wang X; Huang L; Rathnachalam R; Beals JM; Kuhstoss S
    Biochemistry; 2005 Aug; 44(33):11106-14. PubMed ID: 16101294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation.
    Ehlers M; Grötzinger J; Fischer M; Bos HK; Brakenhoff JP; Rose-John S
    J Interferon Cytokine Res; 1996 Aug; 16(8):569-76. PubMed ID: 8877726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.
    Schraufstätter IU; Barritt DS; Ma M; Oades ZG; Cochrane CG
    J Immunol; 1993 Dec; 151(11):6418-28. PubMed ID: 8245475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of critical regions within the TIR domain of IL-1 receptor type I.
    Radons J; Falk W; Dove S
    Int J Biochem Cell Biol; 2015 Nov; 68():15-20. PubMed ID: 26279140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of mouse IL-22 and its four single-amino-acid muteins that act as IL-22 receptor-1 antagonists.
    Niv-Spector L; Shpilman M; Levi-Bober M; Katz M; Varol C; Elinav E; Gertler A
    Protein Eng Des Sel; 2012 Aug; 25(8):397-404. PubMed ID: 22691704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the peptide-antipeptide interactions in interleukin-1 receptor system.
    Kluczyk A; Cebrat M; Zbozień-Pacamaj R; Lisowski M; Stefanowicz P; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2004; 51(1):57-66. PubMed ID: 15094825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and identification of interleukin-1 receptors on bovine fibroblasts.
    Lederer J; Czuprynski C
    Mol Immunol; 1993 Feb; 30(2):191-6. PubMed ID: 8429834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling of fish interleukin-1 and its receptor.
    Scapigliati G; Costantini S; Colonna G; Facchiano A; Buonocore F; Bossù P; Cunningham C; Holland JW; Secombes CJ
    Dev Comp Immunol; 2004 May; 28(5):429-41. PubMed ID: 15062642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.